Digital strategy boosts prescriptions of SGLT2 inhibitors in patients with heart failure

MUNICH — A digital strategy involving an emailed letter inviting patients with heart failure to be evaluated by a specialist for SGLT2 inhibitor therapy dramatically increased SGLT2 inhibitor prescriptions, researchers reported. For the EMAIL-HF registry-based randomized trial, presented at the European Society of Cardiology Congress, researchers identified all patients with HF in the